122 related articles for article (PubMed ID: 22622427)
1. Galectin-1 in melanoma biology and related neo-angiogenesis processes.
Mathieu V; de Lassalle EM; Toelen J; Mohr T; Bellahcène A; Van Goietsenoven G; Verschuere T; Bouzin C; Debyser Z; De Vleeschouwer S; Van Gool S; Poirier F; Castronovo V; Kiss R; Feron O
J Invest Dermatol; 2012 Sep; 132(9):2245-54. PubMed ID: 22622427
[TBL] [Abstract][Full Text] [Related]
2. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
[TBL] [Abstract][Full Text] [Related]
3. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
4. Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts.
Zang G; Gustafsson K; Jamalpour M; Hong J; Genové G; Welsh M
BMC Cancer; 2015 Apr; 15():234. PubMed ID: 25885274
[TBL] [Abstract][Full Text] [Related]
5. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
Zhang W; Tang B; Huang Q; Hua Z
J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
[TBL] [Abstract][Full Text] [Related]
6. Tumor cells secrete galectin-1 to enhance endothelial cell activity.
Thijssen VL; Barkan B; Shoji H; Aries IM; Mathieu V; Deltour L; Hackeng TM; Kiss R; Kloog Y; Poirier F; Griffioen AW
Cancer Res; 2010 Aug; 70(15):6216-24. PubMed ID: 20647324
[TBL] [Abstract][Full Text] [Related]
7. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
[TBL] [Abstract][Full Text] [Related]
8. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.
Thijssen VL; Postel R; Brandwijk RJ; Dings RP; Nesmelova I; Satijn S; Verhofstad N; Nakabeppu Y; Baum LG; Bakkers J; Mayo KH; Poirier F; Griffioen AW
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15975-80. PubMed ID: 17043243
[TBL] [Abstract][Full Text] [Related]
9. N-glycans and metastasis in galectin-3 transgenic mice.
More SK; Srinivasan N; Budnar S; Bane SM; Upadhya A; Thorat RA; Ingle AD; Chiplunkar SV; Kalraiya RD
Biochem Biophys Res Commun; 2015 May; 460(2):302-7. PubMed ID: 25791476
[TBL] [Abstract][Full Text] [Related]
10. Host kinin B1 receptor plays a protective role against melanoma progression.
Maria AG; Dillenburg-Pilla P; Reis RI; Floriano EM; Tefé-Silva C; Ramos SG; Pesquero JB; Nahmias C; Costa-Neto CM
Sci Rep; 2016 Feb; 6():22078. PubMed ID: 26898917
[TBL] [Abstract][Full Text] [Related]
11. Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion.
Szebeni GJ; Kriston-Pál É; Blazsó P; Katona RL; Novák J; Szabó E; Czibula Á; Fajka-Boja R; Hegyi B; Uher F; Krenács L; Joó G; Monostori É
PLoS One; 2012; 7(7):e41372. PubMed ID: 22844466
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells.
Dooley TP; Stamp-Cole M; Ouding RJ
Lab Anim Sci; 1993 Feb; 43(1):48-57. PubMed ID: 7681492
[TBL] [Abstract][Full Text] [Related]
13. Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.
Storti P; Marchica V; Airoldi I; Donofrio G; Fiorini E; Ferri V; Guasco D; Todoerti K; Silbermann R; Anderson JL; Zhao W; Agnelli L; Bolzoni M; Martella E; Mancini C; Campanini N; Noonan DM; Petronini PG; Neri A; Aversa F; Roodman GD; Giuliani N
Leukemia; 2016 Dec; 30(12):2351-2363. PubMed ID: 27311934
[TBL] [Abstract][Full Text] [Related]
14. Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis.
Bastón JI; Barañao RI; Ricci AG; Bilotas MA; Olivares CN; Singla JJ; Gonzalez AM; Stupirski JC; Croci DO; Rabinovich GA; Meresman GF
J Pathol; 2014 Nov; 234(3):329-37. PubMed ID: 24979200
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.
Kuo P; Bratman SV; Shultz DB; von Eyben R; Chan C; Wang Z; Say C; Gupta A; Loo BW; Giaccia AJ; Koong AC; Diehn M; Le QT
Clin Cancer Res; 2014 Nov; 20(21):5558-69. PubMed ID: 25189484
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 Inhibits Cancer Metastasis by Negatively Regulating Integrin β3 Expression.
Hayashi Y; Jia W; Kidoya H; Muramatsu F; Tsukada Y; Takakura N
Am J Pathol; 2019 Apr; 189(4):900-910. PubMed ID: 30653955
[TBL] [Abstract][Full Text] [Related]
17. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
[TBL] [Abstract][Full Text] [Related]
18. Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential.
Yazawa EM; Geddes-Sweeney JE; Cedeno-Laurent F; Walley KC; Barthel SR; Opperman MJ; Liang J; Lin JY; Schatton T; Laga AC; Mihm MC; Qureshi AA; Widlund HR; Murphy GF; Dimitroff CJ
J Invest Dermatol; 2015 Jul; 135(7):1849-1862. PubMed ID: 25756799
[TBL] [Abstract][Full Text] [Related]
19. Galectin-8: a matricellular lectin with key roles in angiogenesis.
Troncoso MF; Ferragut F; Bacigalupo ML; Cárdenas Delgado VM; Nugnes LG; Gentilini L; Laderach D; Wolfenstein-Todel C; Compagno D; Rabinovich GA; Elola MT
Glycobiology; 2014 Oct; 24(10):907-14. PubMed ID: 24939370
[TBL] [Abstract][Full Text] [Related]
20. Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
Ito K; Scott SA; Cutler S; Dong LF; Neuzil J; Blanchard H; Ralph SJ
Angiogenesis; 2011 Sep; 14(3):293-307. PubMed ID: 21523436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
